Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin

Francesca Caccuri, Pasqualina D’Ursi, Matteo Uggeri, Antonella Bugatti, Pietro Mazzuca, Alberto Zani, Federica Filippini, Mario Salmona, Doménico Ribatti, Mark Slevin, Alessandro Orro, Wuyuan Lu, Píetro Lió, Robert C. Gallo, Arnaldo CarusoProceedings of the National Academy of Sciences 2020 · DOI

TL;DR

This study reveals that the HIV-1 matrix protein p17 has evolved a specific functional epitope that mimics human erythropoietin (EPO) and activates the common beta chain receptor (βCR), promoting angiogenesis. This EPO-like epitope is present in HIV-1 ancestors but absent in HIV-2 ancestors, suggesting it played a crucial role in HIV-1's enhanced infectivity and human-to-human transmission.

What Problem Does This Paper Address?

HIV-1 has undergone significant evolutionary adaptations to efficiently infect humans and spread. While the HIV-1 matrix protein p17 is known to be involved in various aspects of the viral life cycle and host cell interactions, its precise role in HIV-1's evolutionary success and its divergence from HIV-2 remain areas of active investigation. Specifically, understanding how p17 contributes to HIV-1's enhanced pathogenicity and transmission compared to HIV-2, which generally causes a less severe disease, is a key question. This paper aims to pinpoint specific functional elements within p17 that might explain these evolutionary differences, focusing on its pro-angiogenic capabilities.

Methods

The researchers employed a multi-pronged approach:

  • Peptide Synthesis and Functional Assays: They synthesized eight peptides derived from the HIV-1 p17 protein and tested their ability to promote angiogenesis (tube-like structure formation) and cell migration (wound healing) in human endothelial cells (HUVECs).
  • Receptor Binding and Inhibition Studies: They investigated the receptors involved by using neutralizing antibodies against known receptors (CXCR1, CXCR2) and by employing siRNA to knock down the expression of the common beta chain receptor (βCR). Surface Plasmon Resonance (SPR) was used to confirm direct binding interactions.
  • Molecular Mimicry Analysis: They identified a region in p17 that showed sequence homology to human erythropoietin (EPO) and synthesized EPO-derived peptides to compare their functional activities.
  • Phylogenetic Analysis: They analyzed the evolutionary history of specific p17 fragments across various HIV-1, SIV, and HIV-2 strains to trace the origin and evolution of functional epitopes. This involved constructing phylogenetic trees using neighbor-joining (NJ) and maximum likelihood (ML) methods.

Datasets

Not explicitly discussed as "datasets" in the traditional machine learning sense. The study utilized:

  • Viral Sequences: A dataset of p17 protein sequences from various HIV-1, SIV (SIVcpz, SIVgor, SIVsmm), and HIV-2 strains for phylogenetic analysis.
  • Cell Lines: Human Umbilical Vein Endothelial Cells (HUVECs) were used for in vitro functional assays.

Key Insights and Ideas

  • p17's Dual Functional Epitopes: The HIV-1 p17 protein possesses at least two distinct functional epitopes responsible for its pro-angiogenic activity. One interacts with CXCR1/CXCR2 under stress conditions, while the other, more significantly, interacts with the common beta chain receptor (βCR) and functions under both normal and stressed conditions.
  • EPO Mimicry and βCR Activation: A key finding is that a specific p17 epitope (aa. 37-52, particularly aa. 37-44) exhibits molecular mimicry with human erythropoietin (EPO). This epitope, when activated, triggers angiogenesis via the βCR.
  • Evolutionary Divergence: The EPO-like epitope that activates βCR is present in the matrix proteins of HIV-1 ancestors (SIVcpz and SIVgor) but is absent in HIV-2 and its ancestor (SIVsmm). This suggests a critical evolutionary "switch" occurred in the HIV-1 lineage.
  • βCR as a Key Player: The study strongly implicates βCR as a crucial receptor for p17's pro-angiogenic activity, particularly for the EPO-mimicking epitope. This is a novel finding, as βCR is typically known for its role in signaling for cytokines like IL-3, IL-5, and GM-CSF, and in EPO signaling as part of a heterodimer.
  • Implications for Pathogenicity: The acquisition of this βCR-activating epitope in HIV-1 ancestors is hypothesized to have enhanced viral aggressiveness and facilitated early human-to-human transmission, potentially explaining some of the pathogenic differences between HIV-1 and HIV-2.

Key Results

  • Peptides F2 and F3 derived from p17 demonstrated significant angiogenic and cell migration activity on HUVECs.
  • Peptide F3's angiogenic activity was independent of CXCR1/CXCR2, suggesting a different receptor.
  • The EPO-mimicking peptide F3S and EPO itself promoted angiogenesis in HUVECs.
  • Knocking down βCR expression in HUVECs abolished the angiogenic activity of oligomeric p17, EPO peptide, and F3S peptide.
  • Phylogenetic analysis revealed that the functional epitope responsible for βCR activation is conserved in HIV-1 and its direct ancestors (SIVcpz/gor) but not in HIV-2 and its ancestors (SIVsmm).
  • A 5-amino acid insertion (aa. 45-49) in the p17 sequence was identified as the evolutionary "switch" for βCR-dependent angiogenic activity.

Limitations and Future Work

  • Causality: While the study strongly suggests a role for p17/βCR interaction in enhancing viral aggressiveness and transmission, the authors acknowledge that the current study design does not allow for direct causal inference.
  • Mechanism of Oligomerization: The precise mechanism by which p17 oligomerizes on the cell surface to effectively engage βCR requires further investigation, although interactions with heparan sulfate proteoglycans are suggested as a facilitating factor.
  • Pathogenic Differences: The hypothesis that p17/βCR interaction and abnormal stimulation play a role in sustaining chronic activation and inflammation, thus marking the pathogenic difference between HIV-1 and HIV-2, needs further investigation.
  • Therapeutic Potential: The identification of the βCR-activating epitope on p17 and EPO opens avenues for developing new preventive or treatment strategies aimed at blocking this interaction. Further research could focus on uncovering the βCR active site and exploring the potential risks and benefits of its stimulation.

Summary updated

Abstract

The HIV-1 matrix protein p17 (p17) is a pleiotropic molecule impacting on different cell types. Its interaction with many cellular proteins underlines the importance of the viral protein as a major determinant of human specific adaptation. We previously showed the proangiogenic capability of p17. Here, by integrating functional analysis and receptor binding, we identify a functional epitope that displays molecular mimicry with human erythropoietin (EPO) and promotes angiogenesis through common beta chain receptor (βCR) activation. The functional EPO-like epitope was found to be present in the matrix protein of HIV-1 ancestors SIV originated in chimpanzees (SIVcpz) and gorillas (SIVgor) but not in that of HIV-2 and its ancestor SIVsmm from sooty mangabeys. According to biological data, evolution of the EPO-like epitope showed a clear differentiation between HIV-1/SIVcpz-gor and HIV-2/SIVsmm branches, thus highlighting this epitope on p17 as a divergent signature discriminating HIV-1 and HIV-2 ancestors. P17 is known to enhance HIV-1 replication. Similarly to other βCR ligands, p17 is capable of attracting and activating HIV-1 target cells and promoting a proinflammatory microenvironment. Thus, it is tempting to speculate that acquisition of an epitope on the matrix proteins of HIV-1 ancestors capable of triggering βCR may have represented a critical step to enhance viral aggressiveness and early human-to-human SIVcpz/gor dissemination. The hypothesis that the p17/βCR interaction and βCR abnormal stimulation may also play a role in sustaining chronic activation and inflammation, thus marking the difference between HIV-1 and HIV-2 in term of pathogenicity, needs further investigation.
BibTeX
@inproceedings{caccuri2020evolution,
  author = {Francesca Caccuri and Pasqualina D’Ursi and Matteo Uggeri and Antonella Bugatti and Pietro Mazzuca and Alberto Zani and Federica Filippini and Mario Salmona and Doménico Ribatti and Mark Slevin and Alessandro Orro and Wuyuan Lu and Píetro Lió and Robert C. Gallo and Arnaldo Caruso},
  title = {{Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin}},
  booktitle = {Proceedings of the National Academy of Sciences},
  year = {2020},
  doi = {10.1073/pnas.2021366118},
}
Figure